Previous clinical studies in invasive breast cancer have also demonstrated the association of CAIX with poor outcome, suggesting that CAIX expression is linked to an aggressive phenotype [11, 16, 24, 25]. The gene discussed is CA9; the disease is invasive breast carcinoma.